Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 | P08172 | 2/20 | 0.41 |
| ▸ | CHRM4 | P08173 | 2/20 | 0.41 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.41 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | CES2 | O00748 | 1/20 | 0.38 |
| ▸ | CES1 | P23141 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 3/20 | 0.36 |
| ▸ | GAA | P10253 | 2/20 | 0.35 |
| ▸ | ELANE | P08246 | 1/20 | 0.35 |
| ▸ | ESR1 | P03372 | 1/20 | 0.34 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.34 |
| ▸ | MIF | P14174 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | GLA | P06280 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15492415 | 1.00 | CHRM2 (0.41) | CHRM2CHRM4CHRM1CHRM3SMN1; SMN2 | |
| SCHEMBL18685665 | 1.00 | CHRM2 (0.41) | CHRM2CHRM4CHRM1CHRM3SMN1; SMN2 | |
| SCHEMBL19404105 | 1.00 | CHRM2 (0.41) | CHRM2CHRM4CHRM1CHRM3SMN1; SMN2 | |
| SCHEMBL15247085 | 1.00 | CHRM2 (0.41) | CHRM2CHRM4CHRM1CHRM3SMN1; SMN2 | |
| SCHEMBL19880058 | 1.00 | CHRM2 (0.41) | CHRM2CHRM4CHRM1CHRM3SMN1; SMN2 | |
| SCHEMBL23424118 | 1.00 | CHRM2 (0.41) | CHRM2CHRM4CHRM1CHRM3SMN1; SMN2 | |
| SCHEMBL29572047 | 0.98 | CHRM2 (0.40) | CHRM2CHRM4CHRM1CHRM3SMN1; SMN2 | |
| SCHEMBL9237508 | 0.98 | SMN1; SMN2 (0.38) | CHRM2CHRM4CHRM1CHRM3SMN1; SMN2 | |
| SCHEMBL5339321 | 0.94 | SMN1; SMN2 (0.42) | CHRM2CHRM4CHRM1CHRM3SMN1; SMN2 | |
| SCHEMBL17776136 | 0.90 | MGLL (0.33) | CHRM2CHRM4CHRM1CHRM3SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 74 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119524119-A | Nanoparticle vaccine for mucosal immunity and preparation method and application thereof | 中国科学院过程工程研究所 | 2025-02-28 | — | — | CN | claimed |
| CN-118010978-A | Preparation method of alkaline phosphatase-labeled human epididymal protein 4 antibody | 桂林优利特医疗电子有限公司 | 2024-05-10 | — | — | CN | claimed |
| CN-109496149-B | Formulation of antibodies and drug conjugates thereof | 根马布股份公司 | 2022-10-14 | — | — | CN | claimed |
| CN-112285353-A | Method for improving anti-biotin interference capability and sensitivity of chemiluminescence kit of streptavidin-biotin reaction system | 武汉生之源生物科技股份有限公司 | 2021-01-29 | — | — | CN | claimed |
| CN-119053346-A | Tissue-specific imaging and therapeutic agents targeting proteins expressed on muscle cell surfaces | 建新公司 | 2024-11-29 | — | — | CN | disclosed |
| CN-118217402-A | Combination therapy for C3 inhibition | 阿佩利斯制药有限公司 | 2024-06-21 | — | — | CN | disclosed |
| CN-118010978-A | Preparation method of alkaline phosphatase-labeled human epididymal protein 4 antibody | 桂林优利特医疗电子有限公司 | 2024-05-10 | — | — | CN | disclosed |
| CN-117503905-A | dosing regimen | 阿佩利斯制药有限公司 | 2024-02-06 | — | — | CN | disclosed |
| CN-113156118-B | Diagnostic marker and application thereof in diagnosis of COVID-19 and past infection detection of coronaviruses | 上海交通大学 | 2024-01-12 | — | — | CN | disclosed |
| CN-116999396-A | Modular compositions for removal of soluble biomolecules and related methods | 纳米提克斯有限责任公司 | 2023-11-07 | — | — | CN | disclosed |
| CN-110882376-B | Cell-reactive, long-acting or targeted compstatin analogs and related compositions and methods | 阿佩利斯制药公司 | 2023-10-20 | — | — | CN | disclosed |
| CN-116617410-A | AXL-specific antibody drug conjugates for cancer treatment | 根马布股份公司 | 2023-08-22 | — | — | CN | disclosed |
| US-6800451-B2 | MORE STABLE REACTION OF GLUCOSE WITH A BORONIC ACID COMPOUND SUCH AS 9,10-BISN-(BORONOBENZYL)-N-(3-(METHYACRYLAMIDO) PROPYLAMINO)METHYLANTHRACENE | SENSORS FOR MEDICINE AND SCIENCE, INC. | 2004-10-05 | — | — | US | disclosed |
| WO-2003078424-A1 | DETECTION OF GLUCOSE IN SOLUTIONS ALSO CONTAINING AN ALPHA-HYDROXY ACID OR A BETA-DIKETONE | SENSORS FOR MEDICINE AND SCIENCE, INC. (US) | 2003-09-25 | — | — | WO | disclosed |
| US-20030082663-A1 | Detection of glucose in solutions also containing an alpha-hydroxy acid or a beta-diketone | SENSORS FOR MEDICINE AND SCIENCE, INC. | 2003-05-01 | — | — | US | disclosed |
| US-6068962-A | NOVOLAK RESIN AS AN ALKALI-SOLUBLE COMPONENT; QUINONEDIAZIDE; ACID GENERATOR; ANTHRACENE DERIVATIVE | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2000-05-30 | — | — | US | disclosed |
| CN-1208465-A | Method of determining the hepatic status of an individual, including a liver transplant recipient | BIOTRIN INTELLECTUAL PTY LTD (IE) | 1999-02-17 | — | — | CN | disclosed |
| EP-0831371-A2 | Positive resist composition | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1998-03-25 | — | — | EP | disclosed |
| WO-1990014103-A1 | POLYPEPTIDE-ANTIBODY CONJUGATE FOR INHIBITING CELL ADHESION | SCRIPPS CLINIC AND RESEARCH FOUNDATION (US) | 1990-11-29 | — | — | WO | disclosed |
| US-4401594-A | PROTEOLYTIC ENZYME INHIBIJTORS; CARDIOVASCULAR AND MUSCULAR DISORDERS | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 1983-08-30 | — | — | US | disclosed |